Cargando…
A PTPmu Biomarker is Associated with Increased Survival in Gliomas
An integrated approach has been adopted by the World Health Organization (WHO) for diagnosing brain tumors. This approach relies on the molecular characterization of biopsied tissue in conjunction with standard histology. Diffuse gliomas (grade II to grade IV malignant brain tumors) have a wide rang...
Autores principales: | Johansen, Mette L., Vincent, Jason, Gittleman, Haley, Craig, Sonya E. L., Couce, Marta, Sloan, Andrew E., Barnholtz-Sloan, Jill S., Brady-Kalnay, Susann M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6566278/ https://www.ncbi.nlm.nih.gov/pubmed/31091655 http://dx.doi.org/10.3390/ijms20102372 |
Ejemplares similares
-
Detection of Tumor-Specific PTPmu in Gynecological Cancer and Patient Derived Xenografts
por: Vincent, Jason, et al.
Publicado: (2021) -
Ultrasound-Based Molecular Imaging of Tumors with PTPmu Biomarker-Targeted Nanobubble Contrast Agents
por: Johansen, Mette L., et al.
Publicado: (2021) -
Small molecule antagonists of PTPmu identified by artificial intelligence-based computational screening block glioma cell migration and growth
por: Molyneaux, Kathleen, et al.
Publicado: (2023) -
Artificial Intelligence-Based Computational Screening and Functional Assays Identify Candidate Small Molecule Antagonists of PTPmu-Dependent Adhesion
por: Molyneaux, Kathleen, et al.
Publicado: (2023) -
A novel binding pocket in the D2 domain of protein tyrosine phosphatase mu (PTPmu) guides AI screen to identify small molecules that modulate tumour cell adhesion, growth and migration
por: Molyneaux, Kathleen, et al.
Publicado: (2023)